Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:50 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:47 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:44 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:41 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:38 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:35 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:32 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:30 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:27 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (SBV)

  • SEC News
  • March 27, 2026, 03:23 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text
  • Previous
  • 311
  • 312
  • 313
  • 314
  • 315
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216334)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137520)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin